10:16 AM EST - Bausch + Lomb Corporation : Today announced that the U.S. Food and Drug Administration has granted 510(k) clearance for the Bi-Blade+ advanced dual-port vitrectomy cutter and the Adaptive Fluidics advanced update on the Stellaris Elite® Vision Enhancement System. Bausch + Lomb Corporation
shares T.BLCO are trading up $0.95 at $23.10.
